AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 36 filers reported holding AXSOME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $202,955 | -97.0% | 2,550 | -97.4% | 0.00% | -100.0% |
| Q3 2023 | $6,762,626 | +96.5% | 96,761 | +116.9% | 0.02% | +21.4% |
| Q4 2022 | $3,441,232 | -41.8% | 44,616 | -66.4% | 0.01% | -53.3% |
| Q3 2022 | $5,916,000 | +1743.0% | 132,593 | +1480.2% | 0.03% | +1400.0% |
| Q2 2022 | $321,000 | -9.3% | 8,391 | -21.8% | 0.00% | +100.0% |
| Q3 2021 | $354,000 | -76.1% | 10,730 | -51.2% | 0.00% | -83.3% |
| Q2 2021 | $1,484,000 | +109.3% | 22,003 | +75.6% | 0.01% | +50.0% |
| Q1 2021 | $709,000 | -33.9% | 12,529 | -31.3% | 0.00% | -85.2% |
| Q1 2020 | $1,073,000 | +0.8% | 18,234 | +77.1% | 0.03% | +350.0% |
| Q4 2019 | $1,064,000 | +9.6% | 10,297 | -72.7% | 0.01% | -33.3% |
| Q2 2019 | $971,000 | +451.7% | 37,706 | +20.1% | 0.01% | +200.0% |
| Q4 2017 | $176,000 | -5.4% | 31,400 | -6.5% | 0.00% | -25.0% |
| Q3 2017 | $186,000 | – | 33,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |